Inhibition of Histone Methyltransferase, Histone Deacetylase, and β-Catenin Synergistically Enhance the Cardiac Potential of Bone Marrow Cells
Previously, we reported that treatment with the G9a histone methyltransferase inhibitor BIX01294 causes bone marrow mesenchymal stem cells (MSCs) to exhibit a cardiocompetent phenotype, as indicated by the induction of the precardiac markers Mesp1 and brachyury. Here, we report that combining the hi...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Text |
| Language: | English |
| Published: |
Hindawi
2017
|
| Subjects: | |
| Online Access: | https://pmc.ncbi.nlm.nih.gov/articles/PMC5534312/ https://pubmed.ncbi.nlm.nih.gov/28791052 http://dx.doi.org/10.1155/2017/3464953 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|